The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

In the last few weeks, the FDA has started to limit COVID vaccine approvals, limiting their use in healthy people under 65 ...

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...

The Trump administration’s shift to narrow approval for coronavirus vaccines to only those who are at high risk for severe disease has raised concerns among Americans who came to rely on annual ...

The FDA imposed similar limitations on Novavax’s Covid vaccine when it approved ... Trump administration’s call for tighter restrictions on vaccine eligibility and approvals.

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around ...

The FDA will encourage new clinical trials on the widely used ... such as individuals who are prediabetic or have high blood ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

RFK Jr. removes Covid-19 vaccines from CDC recommendations for healthy children and pregnant women without scientific ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...